S Walter1,2, A Ragoschke-Schumm3, M Lesmeister3, S A Helwig3, M Kettner4, I Q Grunwald5, K Fassbender3. 1. Department of Neurology, Saarland University, Kirrbergerstraße 1, 66421, Homburg, Germany. silke.walter@uks.eu. 2. Neuroscience, Faculty of Medicine, Anglia Ruskin University, Chelmsford, UK. silke.walter@uks.eu. 3. Department of Neurology, Saarland University, Kirrbergerstraße 1, 66421, Homburg, Germany. 4. Department of Neuroradiology, Saarland University, Homburg, Germany. 5. Neuroscience, Faculty of Medicine, Anglia Ruskin University, Chelmsford, UK.
Abstract
BACKGROUND: Acute ischemic stroke is a treatable disease. Moreover, there is increasing evidence supporting mechanical recanalization for large-vessel occlusion, even beyond a strict time window. However, only small numbers of patients receive causal treatment. METHODS: One of the main reasons that patients do not receive causal therapy is their late arrival at the correct target hospital, which, depending on the type of stroke, is either a regional stroke unit or a comprehensive stroke center for interventional treatment. In order to triage patients correctly, a fast and complex diagnostic work-up is necessary, allowing a stroke specialist to decide on the best therapy option. As treatment possibilities become more comprehensive with the need for individualized decisions, the gap between treatment options and practical implementation is increasing. RESULTS: The "mobile stroke unit" concept encompasses the administration of prehospital acute stroke diagnostic work-up, therapy initiation, and triage to the correct hospital using a specially equipped ambulance, staffed with a team specialized in stroke. The concept, which was conceived and first put into practice in Homburg/Saar, Germany, in 2008, is currently spreading with more than 20 active mobile stroke unit centers worldwide. The use of mobile stroke units can reduce the time until stroke treatment by 50% with a tenfold increase of patients treated within the first 60 min of symptom onset. CONCLUSION: The mobile stroke unit concept for acute stroke prehospital management is spreading worldwide. Intensive research is still needed to analyze the best setting for prehospital stroke management.
BACKGROUND: Acute ischemic stroke is a treatable disease. Moreover, there is increasing evidence supporting mechanical recanalization for large-vessel occlusion, even beyond a strict time window. However, only small numbers of patients receive causal treatment. METHODS: One of the main reasons that patients do not receive causal therapy is their late arrival at the correct target hospital, which, depending on the type of stroke, is either a regional stroke unit or a comprehensive stroke center for interventional treatment. In order to triage patients correctly, a fast and complex diagnostic work-up is necessary, allowing a stroke specialist to decide on the best therapy option. As treatment possibilities become more comprehensive with the need for individualized decisions, the gap between treatment options and practical implementation is increasing. RESULTS: The "mobile stroke unit" concept encompasses the administration of prehospital acute stroke diagnostic work-up, therapy initiation, and triage to the correct hospital using a specially equipped ambulance, staffed with a team specialized in stroke. The concept, which was conceived and first put into practice in Homburg/Saar, Germany, in 2008, is currently spreading with more than 20 active mobile stroke unit centers worldwide. The use of mobile stroke units can reduce the time until stroke treatment by 50% with a tenfold increase of patients treated within the first 60 min of symptom onset. CONCLUSION: The mobile stroke unit concept for acute stroke prehospital management is spreading worldwide. Intensive research is still needed to analyze the best setting for prehospital stroke management.
Authors: David Tong; Mathew J Reeves; Adrian F Hernandez; Xin Zhao; DaiWai M Olson; Gregg C Fonarow; Lee H Schwamm; Eric E Smith Journal: Stroke Date: 2012-04-26 Impact factor: 7.914
Authors: Russell Cerejo; Seby John; Andrew B Buletko; Ather Taqui; Ahmed Itrat; Natalie Organek; Sung-Min Cho; Lila Sheikhi; Ken Uchino; Farren Briggs; Andrew P Reimer; Stacey Winners; Gabor Toth; Peter Rasmussen; Muhammad S Hussain Journal: J Neuroimaging Date: 2015-07-14 Impact factor: 2.486
Authors: Martin Ebinger; Benjamin Winter; Matthias Wendt; Joachim E Weber; Carolin Waldschmidt; Michal Rozanski; Alexander Kunz; Peter Koch; Philipp A Kellner; Daniel Gierhake; Kersten Villringer; Jochen B Fiebach; Ulrike Grittner; Andreas Hartmann; Bruno-Marcel Mackert; Matthias Endres; Heinrich J Audebert Journal: JAMA Date: 2014 Apr 23-30 Impact factor: 56.272
Authors: Joao A Gomes; Christine L Ahrens; Muhammad Shazam Hussain; Stacey Winners; Peter A Rasmussen; Ken Uchino Journal: Stroke Date: 2015-04-14 Impact factor: 7.914
Authors: Heinrich Audebert; Klaus Fassbender; M Shazam Hussain; Martin Ebinger; Guillaume Turc; Ken Uchino; Stephen Davis; Anne Alexandrov; James Grotta Journal: Int J Stroke Date: 2017-09-05 Impact factor: 5.266
Authors: Joon-Tae Kim; Gregg C Fonarow; Eric E Smith; Mathew J Reeves; Digvijaya D Navalkele; James C Grotta; Maria V Grau-Sepulveda; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm; Jeffrey L Saver Journal: Circulation Date: 2016-11-04 Impact factor: 29.690
Authors: Ritvij Bowry; Stephanie Parker; Suja S Rajan; Jose-Miguel Yamal; Tzu-Ching Wu; Laura Richardson; Elizabeth Noser; David Persse; Kamilah Jackson; James C Grotta Journal: Stroke Date: 2015-10-27 Impact factor: 7.914
Authors: M R Hov; T Nome; E Zakariassen; D Russell; J Røislien; H M Lossius; C G Lund Journal: Acta Anaesthesiol Scand Date: 2015-05-15 Impact factor: 2.105